technology

Jan 18, 2021

biotechnology_investmentInvestment in biotech is booming. In Europe, the biotechnology and healthcare sector accounted for 20% of overall private equity investment in the first half of 2020, according to data from funds trade body Invest Europe. 

Jan 18, 2021

mirai_house_fidelityFidelity International has bought a research and development property at Leiden Bio Science Park in the Netherlands for €54 million.

Jan 18, 2021

thematic_etfs_sustainabilityEuropean thematic ETFs are said to be among the “big winners” of 2020 as their assets under management almost trebled despite ongoing market turbulence.

Jan 18, 2021

securities_financeDonia Rouigueb, head of sales for securities finance and repo at CACEIS, participated in our recent securities finance roundtable. She reflects on whether asset owners are likely to move their sec lending activity in-house and on broader issues, including steps to standardise market practice.

Jan 14, 2021

Amundi Alto BNY OmnismAmundi has integrated its Alto portfolio management system – a potential challenger to the leading BlackRock Aladdin platform – with the securities servicing platform of BNY Mellon.

Jan 07, 2021

Hong Kong roundtable Dec 2020Our panel of experts in Hong Kong look at how empowering staff through technology is the name of the game since Covid, the accelerating trend towards ESG investment and the major developments in regulation. Chaired by Romil Patel.

Jan 07, 2021

Microsoft asset management operational platformsA group of asset managers including Pimco and State Street are to form a technology company with Microsoft to “transform the industry’s operating model”.

Jan 07, 2021

biotech_investmentMichael Johnson, group head of institutional services at fund administrator Crestbridge, talks to Funds Europe about the role investors play in the development of the biotech industry.

Jan 07, 2021

water_investmentEuropean ETF issuers expect a surge in demand for thematic funds focusing on water, biotechnology, and technology, research shows.

Jan 05, 2021

Healthcare_researchBiotechnology – in the spotlight thanks to Covid-19 – surpasses even digital in terms of its scope to transform this century. Much of its funding comes from private equity, where investors face ethical as well as financial dilemmas. Alex Rolandi reports.

Pages